GENE, vol.523, pp.20-26, 2013 (Journal Indexed in SCI)
Background: The aim of this study was to investigate the individual or combined effects of PPARA-L162V, PPARG-C161T and APOE polymorphisms on hyperlipidemia in coronary heart disease (CHD) patients.